+41 22 700 21 43

US health agencies call for pause of J&J vaccine rollout… the Timing and the Clowns

Apr 13, 2021 | China, Eurozone, Global Macro, Thematic, USA

Bad news about side effects could derail vaccination policies…

If you add the same issue officially highlighted by EMA with AstraZeneca vacinne+ The Brazilian study demonstrating the low efficiency of SINOVAC + The pandemic completely out of control in Brazil coercing France to shut down all flight from Brazil (not official but could be announced), the markets just priced the perfect timing of reopening…

As I said many times to my teams and clients: Investing is like the circus, Timing is everything, and don’t get distracted by the clowns …

 

Share this:
Go to original article

Are we walking backward into another 1929?

This is my first e-book.  
Read More

Geopolitical Collateral Damages vs. Financial Collateral Advantages!

Somes extracts : Given the last point, your scribe believes that while condemnations are almost unanimous, most Western countries will do everything possible to prevent the conflict from spreading to other countries.   Since the Yom Kippur War and throughout the...
Read More

Geopolitical Risk vs. Squeeze vs. the FED…

Some extracts Looking back at Friday's session, it was one of the best days on record for our GTO (+1.6%) "We're not safe from a surprise, so many of the employment figures are revised and skewed." (GMI 06/10/2023). When your scribe wrote these words on Friday...
Read More

The Great Normalization. “Why” is essential, but “Why, Now” is crucial. China is not in Japanification.

Some extracts Your scribe insists we are only in the Great Normalization of our Western economies. After years of dependence on central bank liquidity, making a monkey able to build an asset allocation ...   It's not the "why," as Powell has been repeating his...
Read More

A New Quarter with Positioning and Economies at the Crossroads!

Some extracts : - On Friday morning, your scribe had shared, "Now, the optimal take-off zone seems to be around October 15, which leaves us with a few more complicated days ahead if the bond markets don't calm down unless the CTAs (whose asymmetry is to the buy side)...
Read More

Resilience Facing the Last Bear Barrage! Golden Week in China and India is not China.

Some extracts : Yesterday, we noted the "disaster" that was this revision for Q2: instead of the unchanged 1.7% figure of the second estimate of Q2 GDP, the final figure was a disaster of 0.8%, a 9-sigma deviation from estimates... China has no reason to be ashamed of...
Read More

Resilience in a No-Rules Market! Duration is THE risk! Chinese economy bottoming out and US Treasury Basis Trade to Watch!

Some extracts : We'll come back to these various points, but first, your scribe will recall his convictions in Global Macro even though the markets no longer have any rules: Duration is the main danger in asset allocation. Markets are increasingly ripe for a rebound...
Read More

US to indefinitely extend China waiver for South Korean chipmakers

The U.S. is expected to indefinitely extend a waiver granted to South Korean chipmakers Samsung Electronics and SK Hynix on needing licenses to bring U.S. chip equipment into China, Yonhap news agency reported on Wednesday. The U.S. Commerce Department has discussed...
Read More

Positioning stronger than Fundamental? Flows are Stronger, for now… Improving Entry Points in Risky Assets?

Some extract : Yesterday was symptomatic of our markets: neither fundamentals nor positioning were the cause of asset movements (except for rates), .... According to reports, after the US banking sector experienced a period of turbulence earlier this year, total...
Read More

Big Bet On U.S. Multifamily from The World’s Billionaires

Over the past 10 years, some of the world's richest have more than doubled their investments in apartments globally, with a particularly heavy emphasis on the U.S, Bloomberg reported, citing research from Knight Frank. With oversupply being an issue in the multifamily...
Read More

Categories

Disclaimer

I hereby certify that I am a professional investor

More information about our Privacy Policy